Endothelin-dependent tone limits acetylcholine-induced dilation of resistance coronary vessels after blockade of NO formation in conscious dogs

Hypertension

Volumn 32, Issue 5, 1998, Pages 844-848

  Ming, Zhi ^a   Parent, Robert ^a   Thorin, Éric ^a   Lavallée, Michel ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Acetylcholine; Endothelin; Endothelium; Endothelium derived factors; Microcirculation

Indexed keywords

ACETYLCHOLINE; BOSENTAN; ENDOTHELIN; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC ACTIVITY; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOG; NONHUMAN; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL;

EID: 0031769143     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.5.844     Document Type: Article

References (25)

1. Teerlink JR, Carteaux J-P, Sprecher U, Löffler B-M, Clozel M, Clozel J-P. Role of endogenous endothelin in normal hemodynamic status of anesthetized dogs. Am J Physiol. 1995;268:H432-H440.
2. Thompson A, Valeri CR, Lieberthal W. Endothelin receptor A blockade alters hemodynamic response to nitric oxide inhibition in rats. Am J Physiol. 1995;269:H743-H748.
3. B receptor and nitric oxide synthase blockade induce BQ-123-sensitive pressor effects in the rabbit. Hypertension. 1997;30:1204-1209.
4. Verhaar MC, Strachan FE, Newby DE, Cruden NL, Koomans HA, Rabelink TJ, Webb DJ. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation. 1998;97:752-756.
5. Boulanger CM, Lüscher TF. Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J Clin Invest. 1990;85: 587-590.
6. Boulanger CM, Lüscher TF. Hirudin and nitrates inhibit the thrombin-induced release of endothelin from the intact porcine aorta. Circ Res. 1991;68:1768-1772.
7. Lüscher TF, Yang Z, Tschudi M, von Segesser L, Stulz P, Boulanger C, Siebenmann R, Turina M, Bühler FR. Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res. 1990;66:1088-1094.
8. Lerman A, Webster MWI, Chesebro JH, Edwards WD, Wei C-M, Fuster V, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs. Circulation. 1993;88:2923-2928.
9. Lerman A, Holmes DR Jr, Bell MR, Garratt KN, Nishimura RA, Burnett JC Jr. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation. 1995;92:2426-2431.
10. Richard V, Hogie M, Clozel M, Löffler B-M, Thuillez C. In vivo evidence of an endoihelin-induced vasopressor tone after inhibition of nitric oxide synthesis in rats. Circulation. 1995;91:771-775.
11. ATP channels and nitric oxide in conscious dogs. Circulation. 1997;95:1568-1576.
12. Parent R, Hamdad N, Ming Z, Lavallée M. Contrasting effects of blockade of nitric oxide formation on resistance and conductance coronary vessels in conscious dogs. Cardiovasc Res. 1996;31:555-567.
13. Clozel M, Breu V, Gray GA, Kalina B, Löffler B-M, Burri K, Cassal J, Hirth G, Müller M, Neidhart W, Ramus H. Pharmacological characterization of bosentan, a new potent orally active non-peptide endothelin receptor antagonist. J Pharmacol Exp Ther. 1994;270:228-235.
14. Roux S, Breu V, Giller T, Neidhart W, Ramuz H, Coassolo P, Clozel JP, Clozel M. Ro 61-1790, a new hydrosoluble endothelin antagonist: general pharmacology and effects on experimental cerebral vasospasm. J Pharmacol Exp Ther. 1997;283:1110-1118.
15. B receptor. FEBS Lett. 1996;383:37-41.
16. B receptors in canine coronary arteries. Circ Res. 1994;74:105-114.
17. Forbes RD, Cernacek P, Zheng S, Gomersall M, Guttmann RD. Increased endothelin expression in a rat cardiac allograft model of chronic vascular rejection. Transplantation. 1996;61:791-797.
18. Glantz S. A Primer of Biostatistics. 2nd ed. New York, NY: McGraw-Hill Book Co; 1987:245-277.
19. Winer BJ. Statistical Principles in Experimental Design. 2nd ed. New York. NY: McGraw-Hill Book Co; 1971:514-603.
20. Hasdai D, Holmes DR Jr, Garratt KN, Edwards WD, Lerman A. Mechanical pressure and stretch release endothelin-1 from human atherosclerotic coronary arteries in vivo. Circulation. 1997;95:357-362.
21. G-nitro-L-arginine methyl ester in conscious dogs is abolished after endothelium removal. In: Moncada S, Marletta MA, Hibbs JB Jr, eds. The Biology of Nitric Oxide, I: Physiological and Clinical Aspects. Colchester, UK: Portland Press; 1992:97-101.
22. Clement MG, Albertini M. Differential release of prostacyclin and nitric oxide evoked from pulmonary and systemic vascular beds of the pig by endothelin-1. Prostaglandins. Leukot Essent Fatty Acids. 1996;55: 279-285.
23. De Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A. 1988;85:9797-9800.
24. Harrison VJ, Barnes K, Turner AJ, Wood E, Corder R, Vane JR. Identification of endothelin-1 and big endothelin-1 in secretory vesicles isolated from bovine aortic endothelial cells. Proc Natl Acad Sci U S A. 1995;92:6344-6348.
25. Widmann MD, Weintraub N, Fudge JL, Brooks LA, Dellsperger KC. Cytochrome P-450 pathway in acetylcholine-induced canine coronary microvascular vasodilation in vivo. Am J Physiol. 1998;274:H283-H289.